Feasibility of Reducing Respiratory Drive Using the Through-flow System

Last updated: December 6, 2024
Sponsor: University Health Network, Toronto
Overall Status: Active - Recruiting

Phase

N/A

Condition

Lung Injury

Respiratory Failure

Treatment

Throughflow titration phase

Clinical Study ID

NCT05642832
21-5534
  • Ages > 18
  • All Genders

Study Summary

Mechanical ventilation can lead to diaphragm and lung injury. During mechanical ventilation, the diaphragm could be completely rested or it could be overworked, either of which may cause diaphragm injury. Mechanical stress and strain applied by mechanical ventilation or by the patient's own respiratory muscles can also cause injury to the lungs. Diaphragm and lung injury are associated with increased morbidity and mortality. Throughflow is a novel system that can reduce dead space without the need to increase the tidal ventilation, reducing the ventilatory demands and respiratory drive.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • PaO2/FiO2 less than or equal to 300 at time of screening

  • Oral endotracheal intubation with ETT 7.5 or 8.0 and on invasive mechanicalventilation

  • Bilateral airspace opacities on chest radiograph or chest CT scan

Exclusion

Exclusion Criteria:

  • Contraindication to esophageal catheterization (upper gastrointestinal tract surgerywithin preceding 6 weeks, bleeding esophageal/gastric varices)

  • Intubation for traumatic brain injury or stroke

  • Intracranial hypertension (suspected or diagnosed by medical team)

  • Anticipated liberation from mechanical ventilation within 24 hours

Study Design

Total Participants: 15
Treatment Group(s): 1
Primary Treatment: Throughflow titration phase
Phase:
Study Start date:
January 01, 2024
Estimated Completion Date:
August 31, 2025

Study Description

Patients with acute respiratory failure often develop significant diaphragm weakness during mechanical ventilation. Diaphragm weakness is associated with prolonged duration of mechanical ventilation and higher risk of death. Clinical data and experimental evidence indicate that the ventilator injures the diaphragm via two opposing mechanisms, disuse and excessive loading. Cessation of diaphragm activity leads to rapid disuse atrophy within hours. On the other hand, high inspiratory loads result in myofibril edema, inflammation and contractile dysfunction. In light of this, studies found that patients with an intermediate level of inspiratory effort, similar to that of healthy subjects breathing at rest, exhibited the shortest duration of ventilation.

Arterial CO2 (PaCO2) tension and physiological dead space play an important role in determining the ventilatory requirements and respiratory drive in patients with AHRF.

Throughflow (Neurovent) is a novel system that reduces anatomical dead space by providing a constant flow of fresh gas (i.e., gas that is free of CO2) during inspiration in patients receiving invasive mechanical ventilation. By clearing the CO2 that normally remains in the upper airway after exhalation (anatomical dead space), TF can dramatically reduce anatomical dead space without the need to increase the delivered VT.

Reducing dead space offers a theoretical benefit in mitigating the mechanisms of lung and diaphragm injury during spontaneous breathing by reducing the ventilation demands to the lungs. Animal studies using the TF have shown extremely promising results, however, the impact of reducing anatomical dead space using the TF on gas exchange, ventilation, and respiratory drive in critically ill patients with AHRF is unknown.

Connect with a study center

  • University Health Network

    Toronto, Ontario M5G 2N2
    Canada

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.